Govt Invites Proposals Under Rs 50 Billion Pharma-MedTech Scheme

03 Oct 2025 CW Team

Revised guidelines have been issued to enhance the scheme’s effectiveness. For early-stage projects, MSMEs and startups may seek support of up to Rs 50 million for projects costing up to Rs 900 million. For later-stage projects, companies, MSMEs and startups may apply for assistance up to Rs 10 billion for projects valued at Rs 28.5 billion. Early-stage projects will receive 100 per cent support up to Rs 10 million, and 50 per cent beyond that, capped at Rs 50 million. Later-stage projects will receive 35 per cent support, capped at Rs 10 billion.

In Strategic Priority Innovation (SPI) areas—such as rare diseases, antimicrobial resistance, vaccine-preventable illnesses, tropical vector-borne diseases and pandemic pathogens—later-stage projects may receive 50 per cent assistance, capped at Rs 10 billion.

The scheme also incentivises industry, MSMEs and startups to collaborate with leading academic and government research institutions, offering preferential selection for up to nine early- and late-stage projects involving significant partnerships. Assistance may also be used for in-licensing research outputs from such institutions, linking academic strengths with industry’s capacity to scale technologies to market.

Institutional enablers will be strengthened through Centres of Excellence at seven NIPERs, acting as advanced research hubs. The NIPER Academia-Industry Coordination Committee will further enhance collaboration, while a digital Pharma-MedTech Innovation Exchange will connect innovators with investors, mentors and global opportunities.

The fully digital application process opened on 1 October 2025 via the PRIP portal. By attracting both domestic and international participation, the scheme aims to accelerate affordable, high-quality healthcare solutions, strengthen India’s public health resilience and position the country as a global leader in pharmaceutical and MedTech innovation.

The Department of Pharmaceuticals has opened applications for research and innovation projects under its Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, a landmark initiative aimed at transforming India into a globally competitive, innovation-led hub. With an approved outlay of Rs 50 billion, the scheme is expected to support around 300 projects, catalysing total R&D investment of about Rs 110 billion in new medicines, complex generics, biosimilars and novel medical devices.Revised guidelines have been issued to enhance the scheme’s effectiveness. For early-stage projects, MSMEs and startups may seek support of up to Rs 50 million for projects costing up to Rs 900 million. For later-stage projects, companies, MSMEs and startups may apply for assistance up to Rs 10 billion for projects valued at Rs 28.5 billion. Early-stage projects will receive 100 per cent support up to Rs 10 million, and 50 per cent beyond that, capped at Rs 50 million. Later-stage projects will receive 35 per cent support, capped at Rs 10 billion.In Strategic Priority Innovation (SPI) areas—such as rare diseases, antimicrobial resistance, vaccine-preventable illnesses, tropical vector-borne diseases and pandemic pathogens—later-stage projects may receive 50 per cent assistance, capped at Rs 10 billion.The scheme also incentivises industry, MSMEs and startups to collaborate with leading academic and government research institutions, offering preferential selection for up to nine early- and late-stage projects involving significant partnerships. Assistance may also be used for in-licensing research outputs from such institutions, linking academic strengths with industry’s capacity to scale technologies to market.Institutional enablers will be strengthened through Centres of Excellence at seven NIPERs, acting as advanced research hubs. The NIPER Academia-Industry Coordination Committee will further enhance collaboration, while a digital Pharma-MedTech Innovation Exchange will connect innovators with investors, mentors and global opportunities.The fully digital application process opened on 1 October 2025 via the PRIP portal. By attracting both domestic and international participation, the scheme aims to accelerate affordable, high-quality healthcare solutions, strengthen India’s public health resilience and position the country as a global leader in pharmaceutical and MedTech innovation.

Infrastructure Transport

24 Oct 2025

Bengaluru Unveils Rs 1,200 Bn Infra Upgrade Plan

Bengaluru is set to receive a massive infrastructure boost worth Rs 1,200 billion under new projects planned by the Karnataka government to enhance urban mobility and connectivity. The initiative includes the expansion of the city’s metro network, construction of tunnel roads, elevated corridors, and 500 km of white-topping works to improve road durability. The Bruhat Bengaluru Mahanagara Palike (BBMP) and Bengaluru Metro Rail Corporation Limited (BMRCL) will jointly execute the projects. Key projects include tunnel roads between Hebbal and Mekhri Circle, 25 new signal-free corridors, and ..

Infrastructure Transport

24 Oct 2025

Cochin Shipyard delivers first indigenous ASW vessel ‘Mahe’ to Navy

Cochin Shipyard Limited (CSL) has delivered INS Mahe, the first indigenous Anti-Submarine Warfare Shallow Water Craft (ASW SWC), to the Indian Navy. The vessel is part of an eight-ship series being constructed under the Navy’s “Atmanirbhar Bharat” initiative to strengthen coastal defence capabilities. Designed and built entirely in India, Mahe features advanced sensors and weapon systems for detecting and neutralising underwater threats in coastal waters. The vessel underwent extensive sea trials before delivery, demonstrating high performance and manoeuvrability. This milestone reinfo..

Infrastructure Urban

24 Oct 2025

Vedanta Group to invest Rs 1,000 billion more in Odisha projects

Vedanta Group has announced an additional investment of Rs 1,000 billion in Odisha to expand its operations across metals, energy, and downstream industries. Anil Agarwal, Chairman, made the announcement during the third edition of the Make in Odisha conclave, highlighting the state’s pivotal role in India’s industrial growth.The investment will focus on strengthening Vedanta’s aluminium and copper businesses, establishing new value-added facilities, and boosting employment in the region. The company already operates large-scale plants in Jharsuguda and Lanjigarh, contributing significan..